C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors Purchases New Stake in DaVita Inc. (NYSE:DVA)

C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors acquired a new position in shares of DaVita Inc. (NYSE:DVA - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm acquired 3,994 shares of the company's stock, valued at approximately $597,000.

Other institutional investors also recently bought and sold shares of the company. Franklin Resources Inc. increased its holdings in DaVita by 134.6% during the 3rd quarter. Franklin Resources Inc. now owns 54,901 shares of the company's stock worth $8,885,000 after purchasing an additional 31,502 shares during the period. FMR LLC increased its holdings in DaVita by 659.9% during the 3rd quarter. FMR LLC now owns 177,406 shares of the company's stock worth $29,082,000 after purchasing an additional 154,061 shares during the period. Atom Investors LP purchased a new position in DaVita during the 3rd quarter worth $4,094,000. Assenagon Asset Management S.A. increased its holdings in DaVita by 201.7% during the 4th quarter. Assenagon Asset Management S.A. now owns 74,617 shares of the company's stock worth $11,159,000 after purchasing an additional 49,885 shares during the period. Finally, Neo Ivy Capital Management purchased a new position in DaVita during the 3rd quarter worth $726,000. 90.12% of the stock is currently owned by hedge funds and other institutional investors.

DaVita Stock Down 11.4 %

Shares of NYSE:DVA traded down $20.11 on Monday, reaching $156.95. The company had a trading volume of 5,110,690 shares, compared to its average volume of 534,172. DaVita Inc. has a 52-week low of $118.56 and a 52-week high of $179.60. The firm's 50 day simple moving average is $161.39 and its 200-day simple moving average is $157.80. The firm has a market capitalization of $12.87 billion, a PE ratio of 16.93, a PEG ratio of 0.84 and a beta of 0.94. The company has a current ratio of 1.37, a quick ratio of 1.33 and a debt-to-equity ratio of 15.78.

DaVita (NYSE:DVA - Get Free Report) last announced its quarterly earnings results on Thursday, February 13th. The company reported $2.24 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.14 by $0.10. DaVita had a return on equity of 88.18% and a net margin of 6.53%. As a group, analysts expect that DaVita Inc. will post 9.71 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Separately, Barclays raised their price objective on DaVita from $150.00 to $164.00 and gave the stock an "equal weight" rating in a report on Thursday, October 31st. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $161.80.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.